![Kjell Olmarker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kjell Olmarker
Corporate Officer/Principal bei University of Gothenburg
Aktive Positionen von Kjell Olmarker
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of Gothenburg | Corporate Officer/Principal | - | - |
Karriereverlauf von Kjell Olmarker
Ehemalige bekannte Positionen von Kjell Olmarker
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
STAYBLE THERAPEUTICS AB | Direktor/Vorstandsmitglied | 01.01.2015 | - |
Gründer | 01.01.2015 | - | |
PharmaSurgics In Sweden AB
![]() PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Direktor/Vorstandsmitglied | 01.01.2005 | - |
Gründer | 01.12.2009 | - |
Statistik
International
Schweden | 4 |
Operativ
Director/Board Member | 2 |
Founder | 2 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
STAYBLE THERAPEUTICS AB | Health Technology |
Private Unternehmen | 1 |
---|---|
PharmaSurgics In Sweden AB
![]() PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Health Technology |
- Börse
- Insiders
- Kjell Olmarker
- Erfahrung